Novo Nordisk has been around for a long time, but really burst onto the scene with the introduction of Ozempic / Wegovy. Weight-loss is a lucrative business, evidenced by super profits in recent years.
But with the share price way off its highs and growth expectations dropping, is now the time to buy?
